by Prakash Achaary | Aug 12, 2021 | News
CANTON, Mich. (August 12, 2021) – MMS Holdings Inc. (MMS) – an award-winning, data-focused CRO – announced today the launch of its pro-bono support program aimed at advancing research for ultra-rare diseases. Within this program, MMS will select from patient advocacy...
by Prakash Achaary | Jul 28, 2021 | News
Data CRO Expands its Virtual Learning Portfolio with New Life Sciences Courses in Inspection Readiness and Clinical Programming CANTON, Mich. (July 28, 2021) – MMS Holdings (MMS) – an award-winning, data-focused CRO – announced that its learning arm, MMS Academy, has...
by Prakash Achaary | Jul 20, 2021 | Blog
FSP partnership models, when developed to find the right level of oversight, scale, pricing, and governance to meet a Sponsor’s needs, offer a functional provider solution that can benefit an organization in a rapidly evolving pharmaceutical industry. For example, The...
by Prakash Achaary | Jul 16, 2021 | Blog
Attention Sponsors, Be Prepared to Publish Your Interim Clinical Study Results Right now, imagining that Sponsors would be required to publish the results of their interim analysis before the end of the study seems impossible. However, this will eventually become an...
by Prakash Achaary | Jul 15, 2021 | Blog
Combination Products: Understanding and Appreciation of CMC Regulatory Considerations for Successful Submission Planning Whitepaper [Fill out the form below to access the whitepaper] Combination products have emerged as powerful technologies for delivering...
